Fair Values of Assets and Liabilities (Tables)

6 Months Ended

Jun. 30, 2015

Schedule of balances of assets and liabilities measured at fair value on a recurring basis

The following tables present the balances of assets and liabilities of Ameriprise Financial measured at fair value on a recurring basis:



	June 30, 2015
	Level 1		Level 2		Level 3		Total
	(in millions)
Assets
Cash equivalents	$	81	$	1,943	$	—	$	2,024
Available-for-Sale securities:
Corporate debt securities	—		15,410		1,509		16,919
Residential mortgage backed securities	—		5,842		279		6,121
Commercial mortgage backed securities	—		2,518		44		2,562
Asset backed securities	—		1,186		135		1,321
State and municipal obligations	—		2,190		—		2,190
U.S. government and agencies obligations	21		35		—		56
Foreign government bonds and obligations	—		239		—		239
Common stocks	5		8		6		19
Total Available-for-Sale securities	26		27,428		1,973		29,427
Trading securities	5		29		1		35
Separate account assets	—		83,704		—		83,704
Investments segregated for regulatory purposes	551		—		—		551
Other assets:
Interest rate derivative contracts	—		1,643		—		1,643
Equity derivative contracts	226		1,859		—		2,085
Credit derivative contracts	—		9		—		9
Foreign exchange derivative contracts	1		42		—		43
Other derivative contracts	—		17		—		17
Total other assets	227		3,570		—		3,797
Total assets at fair value	$	890	$	116,674	$	1,974	$	119,538

Liabilities
Policyholder account balances, future policy benefits and claims:
EIA embedded derivatives	$	—	$	6	$	—	$	6
IUL embedded derivatives	—		—		292		292
GMWB and GMAB embedded derivatives	—		—		235		235		⁽¹⁾
Total policyholder account balances, future policy benefits and claims	—		6		527		533		⁽²⁾
Customer deposits	—		4		—		4
Other liabilities:
Interest rate derivative contracts	—		1,022		—		1,022
Equity derivative contracts	307		2,292		—		2,599
Foreign exchange derivative contracts	—		5		—		5
Other derivative contracts	—		115		—		115
Other	4		18		—		22
Total other liabilities	311		3,452		—		3,763
Total liabilities at fair value	$	311	$	3,462	$	527	$	4,300

⁽¹⁾ The fair value of the GMWB and GMAB embedded derivatives included $541 million of individual contracts in a liability position and $306 million of individual contracts in an asset position.


⁽²⁾	The Company’s adjustment for nonperformance risk resulted in a $300 million cumulative decrease to the embedded derivatives.



	December 31, 2014
	Level 1		Level 2		Level 3		Total
	(in millions)
Assets
Cash equivalents	$	27	$	1,930	$	—	$	1,957
Available-for-Sale securities:
Corporate debt securities	—		15,647		1,518		17,165
Residential mortgage backed securities	—		6,001		206		6,207
Commercial mortgage backed securities	—		2,539		91		2,630
Asset backed securities	—		1,301		169		1,470
State and municipal obligations	—		2,239		—		2,239
U.S. government and agencies obligations	12		35		—		47
Foreign government bonds and obligations	—		251		—		251
Common stocks	5		7		6		18
Total Available-for-Sale securities	17		28,020		1,990		30,027
Trading securities	54		28		1		83
Separate account assets	—		83,256		—		83,256
Other assets:
Interest rate derivative contracts	—		2,031		—		2,031
Equity derivative contracts	282		1,757		—		2,039
Foreign exchange derivative contracts	1		29		—		30
Other derivative contracts	—		1		—		1
Total other assets	283		3,818		—		4,101
Total assets at fair value	$	381	$	117,052	$	1,991	$	119,424

Liabilities
Policyholder account balances, future policy benefits and claims:
EIA embedded derivatives	$	—	$	6	$	—	$	6
IUL embedded derivatives	—		—		242		242
GMWB and GMAB embedded derivatives	—		—		479		479		⁽¹⁾
Total policyholder account balances, future policy benefits and claims	—		6		721		727		⁽²⁾
Customer deposits	—		6		—		6
Other liabilities:
Interest rate derivative contracts	—		1,136		—		1,136
Equity derivative contracts	376		2,326		—		2,702
Foreign exchange derivative contracts	1		2		—		3
Other derivative contracts	—		114		—		114
Other	—		12		—		12
Total other liabilities	377		3,590		—		3,967
Total liabilities at fair value	$	377	$	3,602	$	721	$	4,700


⁽¹⁾	The fair value of the GMWB and GMAB embedded derivatives included $700 million of individual contracts in a liability position and $221 million of individual contracts in an asset position.


⁽²⁾	The Company’s adjustment for nonperformance risk resulted in a $311 million cumulative decrease to the embedded derivatives.

Summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis



	Available-for-Sale Securities
	Corporate Debt Securities			Residential Mortgage Backed Securities			Commercial Mortgage Backed Securities			Asset Backed Securities			Common Stocks			Total				Trading Securities
	(in millions)
Balance, January 1, 2015	$	1,518		$	206		$	91		$	169		$	6		$	1,990			$	1
Total gains (losses) included in:
Net income	(1		)	—			—			—			—			(1		)	⁽¹⁾	—
Other comprehensive income	(6		)	—			—			—			1			(5		)		—
Purchases	55			219			41			32			—			347				—
Settlements	(57		)	(22		)	(3		)	(14		)	—			(96		)		—
Transfers into Level 3	—			—			6			—			—			6				—
Transfers out of Level 3	—			(124		)	(91		)	(52		)	(1		)	(268		)		—
Balance, June 30, 2015	$	1,509		$	279		$	44		$	135		$	6		$	1,973			$	1

Changes in unrealized losses relating to assets held at June 30, 2015 included in:
Net investment income	$	(1	)	$	—		$	—		$	—		$	—		$	(1	)		$	—

⁽¹⁾ Included in net investment income in the Consolidated Statements of Operations.



	Policyholder Account Balances, Future Policy Benefits and Claims
	IUL Embedded Derivatives				GMWB and GMAB Embedded Derivatives				Total
	(in millions)
Balance, January 1, 2015	$	242			$	479			$	721
Total (gains) losses included in:
Net income	14			⁽¹⁾	(379		)	⁽²⁾	(365		)
Issues	45				128				173
Settlements	(9		)		7				(2		)
Balance, June 30, 2015	$	292			$	235			$	527

Changes in unrealized (gains) losses relating to liabilities held at June 30, 2015 included in:
Interest credited to fixed accounts	$	14			$	—			$	14
Benefits, claims, losses and settlement expenses	—				(373		)		(373		)

⁽¹⁾ Included in interest credited to fixed accounts in the Consolidated Statements of Operations.

⁽²⁾ Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.



	Available-for-Sale Securities
	Corporate Debt Securities			Residential Mortgage Backed Securities			Commercial Mortgage Backed Securities			Asset Backed Securities			Common Stocks		Total				Trading Securities			Other Derivative Contracts
	(in millions)
Balance, January 1, 2014	$	1,640		$	187		$	30		$	260		$	6	$	2,123			$	2		$	—
Total gains (losses) included in:
Net income	(1		)	—			—			1			—		—			⁽¹⁾	—			—
Other comprehensive income	16			—			—			—			—		16				—			—
Purchases	122			218			60			21			—		421				1			1
Sales	(11		)	—			—			—			—		(11		)		(2		)	—
Settlements	(201		)	(12		)	—			(8		)	—		(221		)		—			—
Transfers out of Level 3	—			(179		)	(75		)	(89		)	—		(343		)		—			—
Balance, June 30, 2014	$	1,565		$	214		$	15		$	185		$	6	$	1,985			$	1		$	1

Changes in unrealized gains (losses) relating to assets held at June 30, 2014 included in:
Net investment income	$	(1	)	$	—		$	—		$	1		$	—	$	—			$	—		$	—

⁽¹⁾ Included in net investment income in the Consolidated Statements of Operations.



	Policyholder Account Balances, Future Policy Benefits and Claims
	IUL Embedded Derivatives				GMWB and GMAB Embedded Derivatives				Total
	(in millions)
Balance, January 1, 2014	$	125			$	(575	)		$	(450	)
Total losses included in:
Net income	14			⁽¹⁾	120			⁽²⁾	134
Issues	48				119				167
Settlements	(3		)		(11		)		(14		)
Balance, June 30, 2014	$	184			$	(347	)		$	(163	)

Changes in unrealized losses relating to liabilities held at June 30, 2014 included in:
Interest credited to fixed accounts	$	14			$	—			$	14
Benefits, claims, losses and settlement expenses	—				119				119

⁽¹⁾ Included in interest credited to fixed accounts in the Consolidated Statements of Operations.

⁽²⁾ Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.

Significant unobservable inputs used in the fair value measurements

The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities:



	June 30, 2015
	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average
	(in millions)
Corporate debt securities (private placements)	$	1,490	Discounted cash flow	Yield/spread to U.S. Treasuries	1.1	%	–	3.5%	1.5%
IUL embedded derivatives	$	292	Discounted cash flow	Nonperformance risk⁽¹⁾	67			bps
GMWB and GMAB embedded derivatives	$	235	Discounted cash flow	Utilization of guaranteed withdrawals⁽²⁾	0.0	%	–	51.1%
				Surrender rate	0.0	%	–	59.1%
				Market volatility⁽³⁾	5.3	%	–	21.0%
				Nonperformance risk⁽¹⁾	67			bps
				Elective contractholder strategy allocations⁽⁴⁾	0.0	%	–	3.0%



	December 31, 2014
	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average
	(in millions)
Corporate debt securities (private placements)	$	1,476	Discounted cash flow	Yield/spread to U.S. Treasuries	1.0	%	–	3.9%	1.5%
IUL embedded derivatives	$	242	Discounted cash flow	Nonperformance risk⁽¹⁾	65			bps
GMWB and GMAB embedded derivatives	$	479	Discounted cash flow	Utilization of guaranteed withdrawals⁽²⁾	0.0	%	–	51.1%
				Surrender rate	0.0	%	–	59.1%
				Market volatility⁽³⁾	5.2	%	–	20.9%
				Nonperformance risk⁽¹⁾	65			bps
				Elective contractholder strategy allocations⁽⁴⁾	0.0	%	–	3.0%

⁽¹⁾ The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives.


⁽²⁾	The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year.


⁽³⁾	Market volatility is implied volatility of fund of funds and managed volatility funds.


⁽⁴⁾	The elective allocation represents the percentage of contractholders that are assumed to electively switch their investment allocation to a different allocation model.

Schedule of carrying value and the estimated fair value of financial instruments that are not reported at fair value

The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value. All other financial instruments that are reported at fair value have been included above in the tables with balances of assets and liabilities Ameriprise Financial measured at fair value on a recurring basis.



	June 30, 2015
	Carrying Value		Fair Value
	Carrying Value		Level 1		Level 2		Level 3		Total
	(in millions)
Financial Assets
Mortgage loans, net	$	3,388	$	—	$	—	$	3,433	$	3,433
Policy and certificate loans	817		—		1		802		803
Receivables	1,611		284		1,326		4		1,614
Restricted and segregated cash	1,940		1,940		—		—		1,940
Other investments and assets	531		—		467		65		532

Financial Liabilities
Policyholder account balances, future policy benefits and claims	$	12,016	$	—	$	—	$	12,803	$	12,803
Investment certificate reserves	4,349		—		—		4,344		4,344
Brokerage customer deposits	3,471		3,471		—		—		3,471
Separate account liabilities	4,767		—		4,767		—		4,767
Debt and other liabilities	3,663		364		3,400		104		3,868



	December 31, 2014
	Carrying Value		Fair Value
	Carrying Value		Level 1		Level 2		Level 3		Total
	(in millions)
Financial Assets
Mortgage loans, net	$	3,440	$	—	$	—	$	3,512	$	3,512
Policy and certificate loans	806		—		1		793		794
Receivables	1,418		215		1,200		3		1,418
Restricted and segregated cash	2,614		2,614		—		—		2,614
Other investments and assets	551		—		460		84		544

Financial Liabilities
Policyholder account balances, future policy benefits and claims	$	12,979	$	—	$	—	$	13,996	$	13,996
Investment certificate reserves	4,201		—		—		4,195		4,195
Brokerage customer deposits	3,465		3,465		—		—		3,465
Separate account liabilities	4,478		—		4,478		—		4,478
Debt and other liabilities	3,576		261		3,446		121		3,828